| Affiliation: | 1. CIRI, International Center for Infectiology Research, Team EVIR, Université de Lyon, Lyon, France;2. Inserm, U1111, Lyon, France;3. Ecole Normale Supérieure de Lyon, Lyon, France;4. Université Claude Bernard Lyon 1, Centre International de Recherche en Infectiologie, Lyon, France;5. CNRS, UMR5308, Lyon, France;6. LabEx Ecofect, Université de Lyon, Lyon, France;7. Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), équipe “contrôle métabolique des morts cellulaires”, Nice 06204, France;1. San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milan, Italy;2. Milan Unit, IRGB-CNR, Milan, Italy;3. Vita-Salute San Raffaele University, Milan, Italy;4. MolMed S.p.a., Milan, Italy;5. Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany;6. Viral Pathogens and Biosafety Unit, San Raffaele Institute, Milan, Italy;7. Department of Pediatrics, Children''s Hospital Bambino Gesù, Rome, Italy;8. University of Rome Tor Vergata, Rome, Italy;9. Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands;10. Pediatric Clinical Research Unit, San Raffaele Scientific Institute, Milan, Italy;1. Department of Chemistry, State University of New York at Stony Brook, Stony Brook, NY 11794-3400, USA;2. Institute of Chemical Biology and Drug Discovery, State University of New York at Stony Brook, Stony Brook, NY 11794-3400, USA;1. Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany;;2. Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany;;3. Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany;;4. Irene Schneider Consulting, Hanau, Germany;;5. International Center for Infectiology, Research Team Enveloped Viruses, Vectors and Innate Responses, INSERM, Unité 1111, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, University of Lyon, Lyon, France;;6. Translational Oncology at the University Hospital Mainz, Mainz, Germany;;7. Université Côte d''Azur, INSERM, Centre Méditerranéen de Médecine Moléculaire, Nice, France;1. UCL Cancer Institute, University College London, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK;2. Autolus Limited, Forest House, 58 Wood Lane, London W12 7RZ, UK;3. School of Cancer & Pharmaceutical Sciences, King’s College London, Molecular Medicine Group, The Rayne Institute, 123 Coldharbour Lane, London SE5 9NU, UK;4. National Institute for Biological Standards and Control-MHRA, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QC, UK;5. Division of Infection and Immunity, University College London, Rayne Building, 5 University Street, London WC1E 6JF, UK;1. Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany;2. Department of Medicine, Hematology/Oncology, JW-Goethe-University, Frankfurt/M, Germany;3. Department of Immunohematology and Blood Transfusion (IHB) Leiden University Medical Center, Leiden, Netherlands;4. Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany;5. Institute for Transfusion Medicine and Immune Hematology, Clinics of the Johann Wolfgang Goethe University, German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen, Frankfurt am Main, Hessen, Germany;6. Department of Cell Biology, University Medical Center Groningen, Groningen, Netherlands;7. Current address: Division of Pediatric Hematology/Oncology, Boston Children''s Hospital, Harvard Medical School, Boston, Massachusetts, USA;8. Current address: Experimental Cell Therapy and Hematology, Department of Transfusion Medicine, Cell Therapy and Haemostaseology, Ludwig Maximilian University Hospital Munich, Munich, Germany;9. Current address: Division of Haematology/Transfusion Medicine, Paul-Ehrlich-Institut, Langen, Germany |
